Dihydroergotamine Mesylate Nasal
NDC 69097-503, Dihydroergotamine Mesylate Nasal, spray, metered, from Cipla USA Inc..
- Product NDC
- 69097-503
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212907
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIHYDROERGOTAMINE MESYLATE4 mg/mL
Pharmacologic classes
Ergotamine Derivative [EPC]; Ergotamines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-503-27 | 69097050327 | 8 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL |
| 69097-503-31 | 69097050331 | 1 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1ecb2311-eee3-4230-a019-a3496308cff1NADAC price for package 69097050327
GET /v1/drugs/nadac/69097050327NADAC price for package 69097050331
GET /v1/drugs/nadac/69097050331
Use it
Look up 69097-503 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.